NPs Basic Information
|
Name |
Pestalopyrone A
|
| Molecular Formula | C19H28O5 | |
| IUPAC Name* |
3-butan-2-yl-6-[(3S)-3-hydroxybutan-2-yl]-12-methyl-2,4,11-trioxatricyclo[7.4.0.03,7]trideca-1(9),12-dien-10-one
|
|
| SMILES |
CCC(C)C12C(CC3=C(O1)C=C(OC3=O)C)C(CO2)C(C)[C@H](C)O
|
|
| InChI |
InChI=1S/C19H28O5/c1-6-10(2)19-16(15(9-22-19)12(4)13(5)20)8-14-17(24-19)7-11(3)23-18(14)21/h7,10,12-13,15-16,20H,6,8-9H2,1-5H3/t10?,12?,13-,15?,16?,19?/m0/s1
|
|
| InChIKey |
KFGVAOTZLKUXAN-UWRIXMGLSA-N
|
|
| Synonyms |
Pestalopyrone A
|
|
| CAS | NA | |
| PubChem CID | 156582700 | |
| ChEMBL ID | NA |
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 336.4 | ALogp: | 3.2 |
| HBD: | 1 | HBA: | 5 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 65.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 24 | QED Weighted: | 0.908 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -4.667 | MDCK Permeability: | 0.00002710 |
| Pgp-inhibitor: | 0.057 | Pgp-substrate: | 0.017 |
| Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.01 |
| 30% Bioavailability (F30%): | 0.639 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.305 | Plasma Protein Binding (PPB): | 88.59% |
| Volume Distribution (VD): | 3.235 | Fu: | 6.43% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.069 | CYP1A2-substrate: | 0.887 |
| CYP2C19-inhibitor: | 0.048 | CYP2C19-substrate: | 0.926 |
| CYP2C9-inhibitor: | 0.143 | CYP2C9-substrate: | 0.219 |
| CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.752 |
| CYP3A4-inhibitor: | 0.067 | CYP3A4-substrate: | 0.538 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 10.608 | Half-life (T1/2): | 0.099 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.051 | Human Hepatotoxicity (H-HT): | 0.917 |
| Drug-inuced Liver Injury (DILI): | 0.703 | AMES Toxicity: | 0.012 |
| Rat Oral Acute Toxicity: | 0.273 | Maximum Recommended Daily Dose: | 0.323 |
| Skin Sensitization: | 0.075 | Carcinogencity: | 0.607 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.01 |
| Respiratory Toxicity: | 0.893 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004425 |  |
1.000 | D0L7AS |  |
0.230 | ||
| ENC004426 |  |
0.714 | D0P1FO |  |
0.217 | ||
| ENC004424 |  |
0.714 | D0Z1WA |  |
0.196 | ||
| ENC004831 |  |
0.318 | D08HUC |  |
0.196 | ||
| ENC002088 |  |
0.318 | D09PJX |  |
0.194 | ||
| ENC006098 |  |
0.307 | D0L5FY |  |
0.194 | ||
| ENC004832 |  |
0.307 | D0Y7LD |  |
0.194 | ||
| ENC002560 |  |
0.307 | D09SSC |  |
0.183 | ||
| ENC002326 |  |
0.289 | D0A4JK |  |
0.182 | ||
| ENC004941 |  |
0.284 | D06REO |  |
0.181 | ||